Therapeutic Goods Administration relaxes the requirements on nicotine as an unregistered medicine

The Therapeutic Goods Administration (TGA) has relaxed requirements on Nicotine as an unregistered medicine by making ‘Authorised Prescriber’ status for doctors just a matter of filling a form on the TGA web portal and receiving Authorisation in 24 hours. This decision paves the way for other novel medicines to be treated in a similar manner.

The TGA have also authorised SAS-B applications for psilocybin and MDMA and the Victorian and WA state governments have issued Schedule 9 licences to manufacturers.

TGA are still considering re-scheduling psilocybin from Schedule 9 to Schedule 8 with a decision due shortly.

Promethean BioPharma is supportive of these changes in the industry which it hopes will improve access to medications for more people.